Dynavax Technologies | Aktywa



Assets Zmiana Data
AbbVie USD 136.17B 1B 2025-03
Adma Biologics USD 488.68M 98.06M 2024-12
Amgen USD 87.9B 1.47B 2025-06
AstraZeneca USD 112.42B 6.17B 2025-06
Biogen USD 28.33B 297.1M 2025-06
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Dynavax Technologies USD 918.45M 27.48M 2025-06
Gilead Sciences USD 55.72B 713M 2025-06
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Merck USD 117.52B 2.4B 2025-06
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
Novartis USD 104.4B 4.45B 2025-06
Pfizer USD 206.1B 1.93B 2025-06
Regeneron Pharmaceuticals USD 38.22B 674M 2025-06
Roche Holding CHF 101.8B 6.02B 2024-12
Sarepta Therapeutics USD 3.68B 214.43M 2025-06
TG Therapeutics USD 702.61M 45.92M 2025-06
Vertex Pharmaceuticals USD 24.04B 1.16B 2025-06


Dynavax Technologies Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.